NCT01816152

Methodology Issues in a Tailored Light Treatment for Persons With Dementia

Phase 1 Methodology Issues in a Tailored Light Treatment for Persons With Dementia

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 45 (actual)
• Sponsor: Icahn School of Medicine at Mount Sinai · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Accepted

Summary

Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alzheimer's disease and related dementia

Detailed description

In a within subjects, randomized placebo control study, a tailored light treatment will be used for short-term (4 weeks). Outcome measures include sleep measures (actigraphy), and questionnaires probing behavior and mood in those who have been diagnosed with Alzheimer's disease and related dementia. After a 4-week washout period, a placebo control inactive light will be used for another 4 weeks.

Conditions

• Sleep Disturbances
• Depression

Interventions

Type	Name	Description
OTHER	Tailored Active intervention	Subjects experience a baseline for 1 week and an active intervention for 4 weeks. The active intervention is a bluish white light source delivering at least 300 lux at the eye of the patient during at least 2 hours daily.
OTHER	Inactive intervention	Subjects experience a baseline for 1 week and an inactive intervention for 4 weeks. The inactive intervention is a yellowish white light source delivering at most 50 lux at the eye of the patient during at least 2 hours daily.

Timeline

• Start date: 2020-01-01
• Primary completion: 2024-05-10
• Completion: 2024-05-10
• First posted: 2013-03-22
• Last updated: 2024-06-04

Locations

2 sites across 1 country: United States